A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
PHASE3
This randomized, placebo-controlled phase III trial is evaluating the benef...
Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE1
This phase I trial studies the side effects and best dose of mirvetuximab s...
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
PHASE2
This phase II trial studies how well docetaxel with carboplatin followed by...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium